Citations for
1DOPEY2
A quantitative assessment of gene expression (QAGE) reveals differential overexpression of DOPEY2, a candidate gene for mental retardation, in Down syndrome brain regions.
Rachidi M, Delezoide AL, Delabar JM, Lopes C.
Int J Dev Neurosci 27(4):393-8. doi: 10.1016/j.ijdevneu.2009.02.001. Epub 2009 Feb 13. 2009
2DOPEY2
C21orf5, a human candidate gene for brain abnormalities and mental retardation in Down syndrome.
Rachidi M, Lopes C, Delezoide AL, Delabar JM.
Cytogenet Genome Res 112(1-2):16-22. Erratum in: Cytogenet Genome Res. 2006;112(3-4):226. 2006
3DOPEY2
C21orf5, a new member of Dopey family involved in morphogenesis, could participate in neurological alterations and mental retardation in Down syndrome.
Rachidi M, Lopes C, Costantine M, Delabar JM.
DNA Res 12(3):203-10. 2005
4DCR, DOPEY2
The differentially expressed C21orf5 gene in the medial temporal-lobe system could play a role in mental retardation in Down syndrome and transgenic mice.
Lopes C, Chettouh Z, Delabar JM, Rachidi M.
Biochem Biophys Res Commun 305(4):915-24. PMID: 12767918 [PubMed - indexed for MEDLINE] 2003
5DOPEY2
C21orf5, a novel human chromosome 21 gene, has a caenorhabditis elegans ortholog (pad-1) required for embryonic patterning.
Guipponi M, Brunschwig K, Chamoun Z, Scott HS, Shibuya K, Kudoh J, Delezoide AL, El Samadi S, Chettouh Z, Rossier C, Shimizu N, Mueller F, Delabar JM, Antonarakis SE.
Genomics 68(1):30-40. 2000
6DOPEY2, DNMT3B, AGPAT3
Genomic sequencing and identification of 33 genes on human chromosome 21.
Kudoh J, Shibuya K, Kawasaki K, Shintani A, Nagamine K, Wang J, Asakawa JJS, Minoshima S, Shimizu N.
Cytogenet Cell Genet 86:17 1999